α-Methyl-5-hydroxytryptamine maleate5-HT2B agonist CAS# 97469-12-0 |
- Dihydroberberine
Catalog No.:BCN2573
CAS No.:483-15-8
- Pectolinarigenin
Catalog No.:BCN5813
CAS No.:520-12-7
- Carnosol
Catalog No.:BCN1055
CAS No.:5957-80-2
- Hypaconine
Catalog No.:BCN8640
CAS No.:63238-68-6
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 97469-12-0 | SDF | Download SDF |
| PubChem ID | 9922558 | Appearance | Powder |
| Formula | C15H18N2O5 | M.Wt | 306.32 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble to 10 mM in water and to 100 mM in DMSO | ||
| Chemical Name | 3-(2-aminopropyl)-1H-indol-5-ol;(Z)-but-2-enedioic acid | ||
| SMILES | CC(CC1=CNC2=C1C=C(C=C2)O)N.C(=CC(=O)O)C(=O)O | ||
| Standard InChIKey | YQNHFSXRABPJLP-BTJKTKAUSA-N | ||
| Standard InChI | InChI=1S/C11H14N2O.C4H4O4/c1-7(12)4-8-6-13-11-3-2-9(14)5-10(8)11;5-3(6)1-2-4(7)8/h2-3,5-7,13-14H,4,12H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1- | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 5-HT2B receptor selective agonist with pKi values of 8.4, 6.1 and 7.3 at 5-HT2B, 5-HT2A and 5-HT2C receptors respectively. |
α-Methyl-5-hydroxytryptamine maleate Dilution Calculator
α-Methyl-5-hydroxytryptamine maleate Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.2646 mL | 16.3228 mL | 32.6456 mL | 65.2912 mL | 81.614 mL |
| 5 mM | 0.6529 mL | 3.2646 mL | 6.5291 mL | 13.0582 mL | 16.3228 mL |
| 10 mM | 0.3265 mL | 1.6323 mL | 3.2646 mL | 6.5291 mL | 8.1614 mL |
| 50 mM | 0.0653 mL | 0.3265 mL | 0.6529 mL | 1.3058 mL | 1.6323 mL |
| 100 mM | 0.0326 mL | 0.1632 mL | 0.3265 mL | 0.6529 mL | 0.8161 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Tanshindiol C
Catalog No.:BCN3125
CAS No.:97465-71-9
- Tanshindiol B
Catalog No.:BCN3124
CAS No.:97465-70-8
- Cycloart-22-ene-3,25-diol
Catalog No.:BCN4525
CAS No.:97456-49-0
- (-)-5'-DMH-CBD
Catalog No.:BCC5769
CAS No.:97452-63-6
- (-)-Mandelic acid benzyl ester
Catalog No.:BCC8374
CAS No.:97415-09-3
- 2',3'-Dehydrosalannol
Catalog No.:BCN4549
CAS No.:97411-50-2
- Tanshindiol A
Catalog No.:BCN3123
CAS No.:97411-46-6
- Cynatratoside A
Catalog No.:BCN7087
CAS No.:97399-96-7
- Paniculidine C
Catalog No.:BCN4524
CAS No.:97399-95-6
- Paniculidine B
Catalog No.:BCN4523
CAS No.:97399-94-5
- Paniculidine A
Catalog No.:BCN4522
CAS No.:97399-93-4
- Aristolactam AIIIa
Catalog No.:BCN4521
CAS No.:97399-91-2
- Pericyclivine
Catalog No.:BCN3974
CAS No.:975-77-9
- Ceftibuten
Catalog No.:BCC5216
CAS No.:97519-39-6
- 3-O-Caffeoyloleanolic acid
Catalog No.:BCN3959
CAS No.:97534-10-6
- Quinelorane hydrochloride
Catalog No.:BCC7100
CAS No.:97548-97-5
- 6-Methylgenistein
Catalog No.:BCN6852
CAS No.:97575-49-0
- Canrenone
Catalog No.:BCC7626
CAS No.:976-71-6
- Isoscoparin-2''-Beta-D-glucopyranoside
Catalog No.:BCN7807
CAS No.:97605-25-9
- Eticlopride hydrochloride
Catalog No.:BCC7193
CAS No.:97612-24-3
- Lucidone B
Catalog No.:BCN8242
CAS No.:97653-93-5
- Ganoderic acid D2
Catalog No.:BCC8989
CAS No.:97653-94-6
- Latrepirdine
Catalog No.:BCC4541
CAS No.:97657-92-6
- Irinotecan
Catalog No.:BCC2490
CAS No.:97682-44-5
5-HT2 receptor subtypes: a family re-united?[Pubmed:7792930]
Trends Pharmacol Sci. 1995 Mar;16(3):105-10.
The current classification for 5-HT2 receptors accommodates three subtypes. In addition to the originally defined 5-HT2 receptor, sanctuary is now provided for the structurally related 5-HT1c receptor (now 5-HT2c) and at least one atypical 5-HT receptor subtype. The strong functional union of this family is reflected in the paucity of ligands that will discriminate between its subtypes and prompts some re-evaluation of the activities of compounds which may now be regarded as nonselective for the receptor subtypes in this class. In this article, Gordon Baxter and colleagues examine the pharmacology of both officially recognized and atypical 5-HT2 receptor subtypes. A number of novel selective agents are highlighted, some of which may prove useful for 5-HT2 receptor classification and, ultimately, clarify the mechanistic basis for current and future therapeutic strategies which target this receptor family.
5-Hydroxytryptamine3 receptors mediate tachycardia in conscious instrumented dogs.[Pubmed:1968974]
J Pharmacol Exp Ther. 1990 Feb;252(2):683-8.
Intravenously administered 5-HT and the 5-HT3 selective agonist, 2CH3-5-HT, and the 5-HT2 selective agonist, alpha-CH3-5-HT, transiently increased heart rate in conscious, instrumented dogs. 5-HT, alpha-CH3-5-HT and 2CH3-5-HT increased systolic blood pressure in conscious dogs. The increase in blood pressure produced by alpha-CH3-5-HT was blocked by the 5-HT2 selective antagonist, LY53857, supporting a role for vascular 5-HT2 receptors in the pressor response to these amines. In contrast, LY53857 did not antagonize tachycardia produced by 2CH3-5-HT. Furthermore, propranolol also did not block 2CH3-5-HT-induced tachycardia, indicating that an indirect neuronal effect to release norepinephrine cannot explain the increase in heart rate to 2CH3-5-HT. Tachycardia to 2CH3-5-HT (as well as to isoproterenol) was modestly inhibited, but never abolished by interruption of the autonomic nervous system with atropine or hexamethonium. 5-HT3 receptor antagonists, zacopride, ICS 205-930 and GR38032F, dose-dependently blocked the tachycardia and pressor response to 2CH3-5-HT. These data establish the presence of a 5-HT3 receptor mediating a direct positive chronotropic effect of 5-HT in conscious dogs, an effect that depends, only minimally, on the presence of an intact autonomic nervous system.
Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs.[Pubmed:3839291]
Nature. 1985 Jul 11-17;316(6024):126-31.
We describe a new class of drugs that selectively block serotonin M-receptors on peripheral neurones. Because of their high affinity, some of these drugs are the most potent of any pharmacological class yet reported. They have allowed the identification of three M-receptor subtypes, one of which is responsible for mediating the painful effects of serotonin in humans.
